{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T11:48:05Z","timestamp":1794656885135,"version":"4.9.1"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1097\/mca.0000000000000325","type":"journal-article","created":{"date-parts":[[2015,11,18]],"date-time":"2015-11-18T13:25:37Z","timestamp":1447853137000},"page":"89-94","source":"Crossref","is-referenced-by-count":4,"title":["Safety and efficacy of a second-generation coronary sirolimus-eluting stent with biodegradable polymers in daily clinical practice"],"prefix":"10.1097","volume":"27","author":[{"given":"Micha\u0142","family":"Hawranek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Desperak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aneta","family":"Ci\u015blak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawe\u0142","family":"G\u0105sior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Gierlotka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"W\u0105s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Chod\u00f3r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Kowalczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Lekston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariusz","family":"G\u0105sior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210204","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(07)61444-5","article-title":". Outcomes associated with drug-eluting and bare-metal stents: a collaborative network metaanalysis.","volume":"370","author":"Stettler","year":"2007","journal-title":"Lancet"},{"key":"R2-5-20210204","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa066633","article-title":"A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents.","volume":"356","author":"Spaulding","year":"2007","journal-title":"N Engl J Med"},{"key":"R3-5-20210204","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1056\/NEJMoa067731","article-title":"Stent thrombosis in randomized clinical trials of drug-eluting stents.","volume":"356","author":"Mauri","year":"2007","journal-title":"N Engl J Med"},{"key":"R4-5-20210204","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1093\/eurheartj\/ehm402","article-title":". Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction.","volume":"28","author":"Kastrati","year":"2007","journal-title":"Eur Heart J"},{"key":"R5-5-20210204","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.jacc.2013.05.022","article-title":". Clinical outcomes with drug-eluting and bare-metal stents in patients with ST-segment elevation myocardial infarction: evidence from a comprehensive network meta-analysis.","volume":"62","author":"Palmerini","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"R6-5-20210204","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1056\/NEJMoa067484","article-title":". Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents.","volume":"356","author":"Kastrati","year":"2007","journal-title":"N Engl J Med"},{"key":"R7-5-20210204","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1056\/NEJMoa067193","article-title":". Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents.","volume":"356","author":"Stone","year":"2007","journal-title":"N Engl J Med"},{"key":"R8-5-20210204","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0140-6736(07)60314-6","article-title":". Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study.","volume":"369","author":"Daemen","year":"2007","journal-title":"Lancet"},{"key":"R9-5-20210204","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/eurheartj\/ehr479","article-title":". Lower risk of stent thrombosis and restenosis with unrestricted use of new-generation drug-eluting stents: a report from the nationwide Swedish Coronary Angiography and Angioplasty Registry (SCAAR).","volume":"33","author":"Sarno","year":"2012","journal-title":"Eur Heart J"},{"key":"R10-5-20210204","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa0910496","article-title":". Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease.","volume":"362","author":"Stone","year":"2010","journal-title":"N Engl J Med"},{"key":"R11-5-20210204","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1056\/NEJMe1001069","article-title":"Second-generation drug-eluting coronary stents.","volume":"362","author":"Lange","year":"2010","journal-title":"N Engl J Med"},{"key":"R12-5-20210204","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jacc.2011.03.013","article-title":"Second-generation drug-eluting stents. Moving the field forward.","volume":"58","author":"Alfonso","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"R13-5-20210204","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.ahj.2007.11.021","article-title":"Comparative safety and efficacy of a sirolimus-eluting versus paclitaxel-eluting stent: a meta-analysis.","volume":"155","author":"Gurm","year":"2008","journal-title":"Am Heart J"},{"key":"R14-5-20210204","doi-asserted-by":"crossref","first-page":"B170","DOI":"10.1016\/j.jacc.2013.08.1312","article-title":". OCT evaluation of the time course of vessel healing following implantation of new generation polymer-coated and sirolimus eluting cobalt-chromium coronary stent system (ALEX OCT study).","volume":"62","author":"Legutko","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"R15-5-20210204","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.jacc.2011.08.007","article-title":". 2011 ACCFAHASCAI guideline for percutaneous coronary intervention.","volume":"58","author":"Levine","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"R16-5-20210204","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1093\/eurheartj\/ehm355","article-title":"Universal definition of myocardial infarction. Joint ESCACCFAHAWHF task force for the redefinition of myocardial infarction.","volume":"28","author":"Thygesen","year":"2007","journal-title":"Eur Heart J"},{"key":"R17-5-20210204","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":". Clinical end points in coronary stent trials: a case for standardized definitions.","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"R18-5-20210204","doi-asserted-by":"crossref","first-page":"896","DOI":"10.4244\/EIJV8I8A138","article-title":"FOCUS registry investigators. Real-world use of the second generation cobalt-chromium sirolimus-eluting stents: 12-months results from the prospective multicenter FOCUS registry.","volume":"8","author":"Zhang","year":"2012","journal-title":"Eurointervention"},{"key":"R19-5-20210204","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jcin.2010.11.006","article-title":". The SPIRIT V study: a clinical evaluation of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with de novo coronary lesions.","volume":"4","author":"Grube","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"R20-5-20210204","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.jcin.2009.10.001","article-title":"E-Five Investigators. Safety and effectiveness of the Endeavor zotarolimus-eluting stent in real-world clinical practice: 12-month data from the E-Five registry.","volume":"2","author":"Lotan","year":"2009","journal-title":"JACC Cardiovasc Interv"},{"key":"R21-5-20210204","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.jacc.2006.03.063","article-title":". Clinical outcomes for sirolimus-eluting stents and polymer-coated paclitaxel-eluting stents in daily practice.","volume":"48","author":"Saia","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"R22-5-20210204","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1161\/CIRCULATIONAHA.104.532242","article-title":". Safety of coronary sirolimus-eluting stents in daily clinical practice: one-year follow-up of the e-Cypher registry.","volume":"113","author":"Urban","year":"2006","journal-title":"Circulation"},{"key":"R23-5-20210204","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1161\/CIRCULATIONAHA.106.667915","article-title":"DEScover Investigators. Outcomes of 6906 patients undergoing percutaneous coronary intervention in the era of drug-eluting stents: report of the DEScover Registry.","volume":"114","author":"Williams","year":"2006","journal-title":"Circulation"},{"key":"R24-5-20210204","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.jacc.2007.06.019","article-title":". Comparative clinical outcomes of paclitaxel and sirolimus-eluting stents: results from a large prospective multicenter registry - STENT group.","volume":"50","author":"Simonton","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"R25-5-20210204","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.amjcard.2007.02.051","article-title":". Long-term clinical outcomes and thrombosis rates of sirolimus-eluting versus paclitaxel-eluting stents in an unselected population with coronary artery disease (REWARDS registry).","volume":"100","author":"Waksman","year":"2007","journal-title":"Am J Cardiol"},{"key":"R26-5-20210204","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/ccd.21618","article-title":". Usage patterns and 2-year outcomes with the TAXUS express stent: results of the ARRIVE 1 registry.","volume":"72","author":"Lasala","year":"2008","journal-title":"Catheter Cardiovasc Interv"},{"key":"R27-5-20210204","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1001\/jama.293.17.2126","article-title":". Incidence, predictors and outcome of thrombosis after successful implantation of drug-eluting stents.","volume":"293","author":"Iakovou","year":"2005","journal-title":"JAMA"}],"container-title":["Coronary Artery Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000000325","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:40:11Z","timestamp":1620960011000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00019501-201603000-00005"}},"subtitle":["a 12-month follow-up of the ALEX registry"],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/mca.0000000000000325","relation":{},"ISSN":["0954-6928"],"issn-type":[{"value":"0954-6928","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]}}}